Menopause Sexless Marriage 

By Sophora Health Editorial Team  ·  Medically reviewed  ·  Published July 2026  ·  Last reviewed July 2026

You still love them. You may still want the marriage. But somewhere along the way, sex disappeared.

Maybe you stopped initiating because desire simply stopped arriving. Maybe sex became uncomfortable or painful, so you began avoiding the moments that might lead to it. Maybe you are exhausted, touched-out, irritated, unable to sleep, and the last thing you want at the end of the day is another person needing something from your body.

And now there is something sitting between you.

They may think you no longer want them. You may be wondering why you cannot make yourself want what you used to want. Perhaps neither of you knows how to talk about it without someone feeling rejected, blamed, or ashamed.

If menopause has coincided with a sexless marriage, the question is rarely just, “How do I get my libido back?”

It may be: What happened to us?

Or even: Is this my marriage now?

It may have tapered off gradually, or it may have gradually become the subject nobody raises anymore. You are not the only couple managing this.

You are probably one of the least likely to have told anyone. And the silence around it is almost certainly making it worse than it needs to be, because the thing that stopped the sex is, in many cases, entirely addressable. That is what this article is about.

How common is this?

What is actually happening

A sexless marriage during menopause is almost never about not loving each other. It is about a set of specific, hormonal, and physiological changes that make sex uncomfortable, undesirable, or simply absent in a way that neither partner fully understands. When those changes are not understood and not named, both partners fill the silence with the worst available interpretation of what the other one’s behaviour means. Which makes everything harder than it already is.

There are typically several things happening at once.

The desire problem

Testosterone drives libido in women, and it has been declining gradually since the early 30s. Oestrogen decline during perimenopause and menopause further reduces the brain’s interest in sex by affecting the serotonin, dopamine, and norepinephrine pathways that make desire possible.

The result is not simply “not in the mood.” It is closer to the signal not arriving at all. The interest that used to arise without effort has gone quiet. This is hormonal. It is not evidence of how you feel about your partner.

The pain problem

Oestrogen keeps vaginal tissue thick, elastic, and lubricated. When it declines, the tissue thins, the natural lubrication reduces, and penetrative sex becomes uncomfortable and then painful in a way that has nothing to do with arousal or attraction.

Up to 75% of women over 65 experience vaginal dryness and up to 40% experience pain during intercourse. Unlike hot flushes, which tend to ease after menopause, vaginal atrophy does not resolve on its own. Without treatment it typically worsens over time.

The pain creates its own cycle. Uncomfortable sex leads to avoidance. Avoidance leads to the partner experiencing rejection without understanding the reason.

The rejected partner withdraws. The withdrawal reads as loss of interest, which reduces desire further. The gap widens. What started as a physical symptom with a straightforward treatment becomes a relational wound that is much harder to address.

The energy and body image problem

Chronic sleep disruption from night sweats leaves many women in a state of permanent fatigue where sex is simply one more demand on a body that has nothing left. Body image during the physical changes of perimenopause, weight redistribution, skin changes, breast changes, reduces the confidence that intimacy requires for many women. Neither of these is a character failing. Both of them are real and documentable effects of the hormonal transition.

The sex stopped for a reason. The reason is hormonal, physiological, and entirely real. It is also, in most cases, addressable. The silence around it is the part that is optional.

Someone important to you needs this too.

WhatsAppiMessageCopy LinkEmail

What this looks like around the world

The hormonal changes are universal. What is not universal is whether women can name them, access treatment for them, or have a cultural framework that permits the conversation at all.

In Islamic cultural contexts, some women hold the belief that fulfilling a spouse’s sexual needs is a religious duty. A meta-ethnography published in 2025 found this creates an additional layer of pressure during menopause: the obligation to engage in sexual activity while experiencing low desire and physical discomfort.

The result is sex that is neither wanted nor comfortable, which helps nobody and is sustained in silence because the conversation requires naming a problem that cultural frameworks have not historically made space for.

A qualitative study in Indonesia found more than half of postmenopausal participants reported significant negative changes in their sexual relationships. Decreased libido, vaginal dryness, and pain during intercourse were the primary causes. These are the same causes as everywhere else. The difference is that in many of these contexts, the treatment options are either unknown or culturally inaccessible.

A systematic review of HRT use in Arab countries found uptake was generally low, with fewer than 20% of participants using it in 11 of the studies reviewed. Barriers included cultural conservatism, risk concerns, and preference for natural approaches.

Local oestrogen works specifically on vaginal tissue, is minimally absorbed, and is appropriate for most women. It is not a topic that reaches women in many of these communities through any existing channel. The treatment that would solve the most pressing physical barrier to intimacy is simply not being discussed.

A grounded theory study of immigrant Muslim women in the UK found they described their experience through three categories: losing control of the body, dealing with menopause alone, and navigating a web of silence.

The web of silence is not unique to Muslim women. It is the near-universal experience: managing this transition without language for it and without a framework that validates it as a legitimate medical problem rather than a personal failing to be accepted without complaint.

In sub-Saharan Africa, menopause is in many communities understood as a positive transition into elder status, which can reduce some of the psychological weight of the transition.

But sexual health within marriage in midlife is rarely discussed openly, and treatment options for vaginal atrophy are almost never part of that conversation. The women who experience pain during intercourse are managing it in private, or they have stopped intercourse and live with whatever consequence that produces in the relationship.

In Japan, where sexual communication within marriage is generally less verbal than in Western cultures, menopausal sexual changes are frequently managed through mutual withdrawal rather than explicit conversation. Research consistently finds lower rates of reported sexual complaints in Japanese postmenopausal women, which is likely to partly reflect a difference in reporting rather than a difference in experience. The silence looks different across cultures. The underlying hormonal reality is the same.

In Latin America, where Catholic cultural frameworks have historically associated sex with reproduction, the loss of reproductive capacity in menopause can create a complex relationship with sexual identity. Some women in this context find that menopause liberates them from the reproductive dimension of sex for the first time, and sexual satisfaction increases. Others, particularly those for whom marital duty was the primary frame for sexual activity, find that desire disappears alongside the reproductive context and nobody addresses why.

What actually helps

Local oestrogen: the most underused solution

If vaginal dryness and pain during intercourse are the primary barriers to intimacy, local oestrogen is the most direct and most effective solution available. Applied directly to vaginal tissue as a cream, pessary, or ring, local oestrogen restores tissue thickness, elasticity, and lubrication with minimal absorption into the bloodstream. It is appropriate for most women including many who cannot use systemic HRT due to hormone-sensitive cancer history or cardiovascular risk. Unlike systemic HRT, it does not require progesterone alongside it. It is significantly underused relative to how many women need it and how well it works.

The REVIVE survey found that healthcare professionals initiated the conversation about vaginal symptoms in only 10% of consultations. Which means the majority of women experiencing pain during intercourse are waiting for their doctor to ask, and their doctor is waiting for them to raise it. This is an information gap that has a simple fix: at your next appointment, name the symptom specifically. “Intercourse has become painful and I want to discuss treatment options.” That sentence is enough to open the conversation.

Systemic HRT

For women where low desire is the primary concern and vaginal symptoms are secondary, systemic HRT that restores oestrogen can improve sexual response, clitoral sensitivity, and libido through its effects on brain chemistry and pelvic blood flow. For many women who start HRT for other symptoms, including hot flushes, sleep, and mood, the return of sexual interest is a welcome and unexpected benefit they did not think to ask about.

Testosterone

Testosterone has good clinical evidence for improving low sexual desire in both perimenopausal and postmenopausal women. The Menopause Society acknowledges this evidence. It is currently prescribed off-label for this indication in most markets. If low desire is the central complaint and oestrogen management alone has not restored it, testosterone is the next conversation to have with a menopause-trained clinician.

Lubricants and moisturisers

Water-based or silicone-based lubricants used during sexual activity reduce friction and discomfort immediately. Vaginal moisturisers used regularly (two to three times per week, not just during sex) maintain tissue hydration over time and reduce the baseline dryness that makes daily life uncomfortable and sex painful. These are not treatments for the underlying cause but they make the experience of intimacy manageable while treatment is established. They are also widely available without prescription in every market where this article will be read.

The conversation with your partner

The most important intervention is also the one most consistently avoided. A partner who understands that the pain is hormonal and real, that it has nothing to do with attraction, and that treatments are being pursued, can move from confusion and withdrawal to patience and collaboration. That shift changes everything about the relational dimension of this problem.

The conversation does not need to be clinical. It can be: “Sex has become physically uncomfortable for me because of hormonal changes. I am dealing with it medically. In the meantime, can we find other ways to be close?” Most partners receive this with relief. The withdrawal they have been interpreting as rejection gets explained. The explanation changes everything.

Expanding what intimacy means

During the period when penetrative sex is painful and treatment is being established, expanding the definition of intimacy reduces the pressure on the specific act that is currently problematic. Physical affection, shared sleep, deliberate touch that does not carry the expectation of intercourse: these maintain connection and create conditions in which sexual desire, as treatment takes effect, has somewhere to return to.

When to see a doctor

If pain during intercourse is present, this is a clinical symptom with clinical solutions and it warrants a medical appointment. You do not need to have stopped having sex entirely before this conversation is appropriate. You need to name the symptom: “Intercourse has become painful since perimenopause began. I want to discuss treatment.” Sophora’s Doctor Prep document can help you put the specific symptoms (when the dryness began, how significant the pain is, whether you are still attempting intercourse or have stopped) into organised language before that appointment.

Questions you are probably asking

Is it normal for sex to stop completely during menopause?

It is common. It is not inevitable and it is not permanent without intervention. Around 30% of women over 50 report their sex lives have stopped. The causes are hormonal and physiological, and most of them are treatable. The question is not whether this happens to other people. The question is whether you want to address it and what the options are for your specific situation.

Can sex actually be better after menopause?

For some women, yes. Freedom from contraception anxiety, freedom from PMS and periods, and for many women a clearer sense of what they want: these can all contribute to a more satisfying sexual experience post-menopause, provided the physical symptoms are addressed. Some postmenopausal women report greater sexual satisfaction than they experienced before menopause. This is a genuine possibility, not a consolation prize, but it depends on the physical symptoms being treated rather than simply accepted.

My partner thinks I am no longer attracted to him. What do I say?

You say this is hormonal, not relational. The desire that has disappeared is testosterone and oestrogen-dependent. It is being managed medically. It is not a verdict on attraction. The most useful sentence is the direct one: “This is about my hormones, not about you. I am addressing it medically. I need your patience and I need you to know that this is not about how I feel about you.” Partners who receive this information almost universally respond with relief rather than defensiveness. Most of them have been trying to construct an explanation from behaviour alone and have been failing.

Does local oestrogen affect the rest of my body?

Local oestrogen applied to vaginal tissue is minimally absorbed into the bloodstream. It works locally where it is applied. It does not carry the same considerations as systemic HRT, and it is appropriate for most women including many who cannot use systemic hormone therapy. This is one of the most important pieces of information in this article because it is the one most likely to remove a barrier. Many women who have been told they cannot use HRT can still use local oestrogen. Ask your doctor specifically.

Someone important to you needs this too.

WhatsAppiMessageCopy LinkEmail

The sex stopped for a reason. The reason is hormonal, physiological, and entirely real. It is also, in most cases, addressable. The silence around it is the part that is optional.

Last reviewed: July 2026  ·  Review due: September 2026  ·  Not therapy. Not medical advice. For your own use and understanding only.  ·  mysophora.com